Juno Therapeutics (Germany)
Juno Therapeutics Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Juno Therapeutics (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
73%
Total
Publications
51
Total Open
Publications
37
Total
Citations
2.1K
Open Access
Percentage
73%
Total
Publications
51
Total Open
Publications
37
Total
Citations
2.1K
Breakdown
Publisher Open
25%
Both
24%
Other Platform Open
24%
Closed
27%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
10
Hybrid 32%
8
No Guarantees 28%
7
Other Platform Open
Domain 71%
17
Institution 33%
8
Preprint 17%
4
Public 4%
1
Other Internet 4%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 17 |
Europe PMC | Domain | 12 |
bioRxiv | Preprint | 3 |
University of Toronto - TSpace | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
Universidad Autónoma de Madrid - Biblos-e Archivo | Institution | 1 |
tum.de OAI-PMH Repository | Institution | 1 |
Technische Universität München - mediaTUM Gesamtbestand | Institution | 1 |
Research Square | Preprint | 1 |
Max Planck Society - MPG.PuRe | Institution | 1 |